• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[现代偏头痛治疗——跨学科长期护理]

[Modern migraine therapy-interdisciplinary long-term care].

作者信息

Göbel Hartmut, Heinze Axel, Heinze-Kuhn Katja, Göbel Carl H H

机构信息

Migräne- und Kopfschmerzzentrum, Neurologisch-verhaltensmedizinischeSchmerzklinik Kiel, Heikendorfer Weg 9-27, 24149, Kiel, Deutschland.

出版信息

Internist (Berl). 2020 Mar;61(3):326-332. doi: 10.1007/s00108-020-00757-5.

DOI:10.1007/s00108-020-00757-5
PMID:32072189
Abstract

Migraine has a very high lifetime prevalence with a severe illness-related burden. As a result, extensive long-term and regular treatment is required, which cannot be covered solely by neurologists. This is particularly the case for the long-term monitoring of migraine, which often takes place over several decades. The diagnosis is made using the diagnostic criteria of the International Headache Society (ICHD-3) based on the clinical phenotype. Owing to often complex neurological symptoms, a detailed weighing up of the differential diagnoses is required, which calls for specialist neurological expertise. The same is true for follow-up appointments of more complex therapy issues. Acute therapy with antiemetics, analgesics, and triptans can, so long as it is effective and is administered not longer than 10 days per month, be carried out by the general practitioner or specialist in internal medicine. This is also true for medical prophylactic treatment with dietary supplements, antihypertensive drugs, and tricyclic antidepressants. If this therapy is unsuccessful, prophylactic substances must be used that require more specialized knowledge, which is also reflected in the formal prescription requirements. Neurologists and pain therapists should then be involved in the treatment. This is particularly true for the use of Onabotulinumtoxin A and monoclonal CGRP-(receptor)-antibodies.

摘要

偏头痛的终生患病率很高,伴有严重的疾病相关负担。因此,需要进行广泛的长期定期治疗,而这仅靠神经科医生无法完全覆盖。偏头痛的长期监测尤其如此,这种监测通常持续数十年。诊断是根据临床表型,使用国际头痛协会(ICHD-3)的诊断标准进行的。由于神经症状往往复杂,需要对鉴别诊断进行详细权衡,这需要专业的神经学专业知识。对于更复杂治疗问题的随访预约也是如此。只要有效且每月使用不超过10天,全科医生或内科专科医生就可以进行使用止吐药、镇痛药和曲坦类药物的急性治疗。使用膳食补充剂、抗高血压药物和三环类抗抑郁药进行药物预防性治疗也是如此。如果这种治疗不成功,则必须使用需要更专业知识的预防性药物,这也反映在正式的处方要求中。此时神经科医生和疼痛治疗师应参与治疗。使用A型肉毒毒素和单克隆CGRP(受体)抗体时尤其如此。

相似文献

1
[Modern migraine therapy-interdisciplinary long-term care].[现代偏头痛治疗——跨学科长期护理]
Internist (Berl). 2020 Mar;61(3):326-332. doi: 10.1007/s00108-020-00757-5.
2
Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018.抗降钙素基因相关肽(CGRP)治疗药物:美国头痛学会第 60 届科学会议(2018 年 6 月,旧金山)后对既往综述的更新。
Headache. 2018 Nov;58 Suppl 3:276-290. doi: 10.1111/head.13417.
3
History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.降钙素基因相关肽(CGRP)拮抗剂治疗的历史和综述:从转化研究到治疗。
Headache. 2018 Nov;58 Suppl 3:238-275. doi: 10.1111/head.13379. Epub 2018 Sep 22.
4
CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.降钙素基因相关肽与偏头痛:阻断降钙素基因相关肽配体和受体在偏头痛治疗中的作用。
Drugs. 2018 Jun;78(9):913-928. doi: 10.1007/s40265-018-0923-5.
5
[Anti-CGRP-based Migraine Medications: A Comprehensive Overview].[基于降钙素基因相关肽的偏头痛药物:全面概述]
Fortschr Neurol Psychiatr. 2024 Jul;92(7-08):277-282. doi: 10.1055/a-2276-2239. Epub 2024 Mar 28.
6
Calcitonin gene-related peptide (CGRP): a new target for migraine.降钙素基因相关肽(CGRP):偏头痛的新靶点。
Annu Rev Pharmacol Toxicol. 2015;55:533-52. doi: 10.1146/annurev-pharmtox-010814-124701. Epub 2014 Oct 8.
7
The CGRP Pathway in Migraine as a Viable Target for Therapies.偏头痛中 CGRP 通路作为一种可行的治疗靶点。
Headache. 2018 May;58 Suppl 1:33-47. doi: 10.1111/head.13305.
8
CGRP as the target of new migraine therapies - successful translation from bench to clinic.降钙素基因相关肽(CGRP)作为新型偏头痛治疗靶点——从实验室到临床的成功转化。
Nat Rev Neurol. 2018 Jun;14(6):338-350. doi: 10.1038/s41582-018-0003-1.
9
Targeting calcitonin gene-related peptide: a new era in migraine therapy.针对降钙素基因相关肽:偏头痛治疗的新时代。
Lancet. 2019 Nov 9;394(10210):1765-1774. doi: 10.1016/S0140-6736(19)32504-8. Epub 2019 Oct 23.
10
CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications.降钙素基因相关肽配体和受体单克隆抗体预防偏头痛:证据回顾与临床意义。
Cephalalgia. 2019 Mar;39(3):445-458. doi: 10.1177/0333102418821662. Epub 2019 Jan 19.

引用本文的文献

1
A Digital Therapeutic Allowing a Personalized Low-Glycemic Nutrition for the Prophylaxis of Migraine: Real World Data from Two Prospective Studies.一种用于偏头痛预防的个性化低血糖营养的数字治疗:来自两项前瞻性研究的真实世界数据。
Nutrients. 2022 Jul 17;14(14):2927. doi: 10.3390/nu14142927.
2
Chronic headache patients' health behavior and health service use 12 months after interdisciplinary treatment - what do they keep in their daily routines?慢性头痛患者接受跨学科治疗 12 个月后的健康行为和卫生服务利用情况——他们在日常生活中保持着哪些习惯?
BMC Neurol. 2022 Apr 21;22(1):149. doi: 10.1186/s12883-022-02646-w.